APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

TB Vaccines

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global TB Vaccines Industry Growth and Trends Forecast to 2032

Report ID 174039940119 December 2025109 pages

Choose your research edition.

Industry ResearchTB Vaccines Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal TB Vaccines Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal TB Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal TB Vaccines Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal TB Vaccines Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global TB Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for TB Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for TB Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for TB Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of TB Vaccines include China National Biotec Group, Sanofi Pasteur, Merck & Co.,Inc, Statens Serum Institut, Serum Institute, Japan BCG Laboratory, InterVax Ltd, India Pvt. Ltd and GreenSignal, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global TB Vaccines market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The TB Vaccines market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global TB Vaccines market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to TB Vaccines.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global TB Vaccines market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

TB Vaccines Market by Company

China National Biotec Group

Sanofi Pasteur

Merck & Co.,Inc

Statens Serum Institut

Serum Institute

Japan BCG Laboratory

InterVax Ltd

India Pvt. Ltd

GreenSignal

Bio Pharma Limited

TB Vaccines Segment by Type

Immunotherapeutic Vaccines

Booster Vaccines

Others

TB Vaccines Segment by Application

Private Clinics

Research Institutes

Hospitals

TB Vaccines Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global TB Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of TB Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of TB Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of TB Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of TB Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Immunotherapeutic Vaccines Table 2. Major Company of Booster Vaccines Table 3. Major Company of Others Table 4. Global TB Vaccines Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global TB Vaccines Sales by Type (2021-2026) & (W Units) Table 6. Global TB Vaccines Sales Market Share in Volume by Type (2021-2026) Table 7. Global TB Vaccines Sales by Type (2021-2026) & (US$ Million) Table 8. Global TB Vaccines Sales Market Share in Value by Type (2021-2026) Table 9. Global TB Vaccines Price by Type (2021-2026) & (US$/Unit) Table 10. Global TB Vaccines Sales by Type (2027-2032) & (W Units) Table 11. Global TB Vaccines Sales Market Share in Volume by Type (2027-2032) Table 12. Global TB Vaccines Sales by Type (2027-2032) & (US$ Million) Table 13. Global TB Vaccines Sales Market Share in Value by Type (2027-2032) Table 14. Global TB Vaccines Price by Type (2027-2032) & (US$/Unit) Table 15. North America TB Vaccines Sales by Type (2021-2026) & (W Units) Table 16. North America TB Vaccines Sales by Type (2021-2026) & (US$ Million) Table 17. Europe TB Vaccines Sales by Type (2021-2026) & (W Units) Table 18. Europe TB Vaccines Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific TB Vaccines Sales by Type (2021-2026) & (W Units) Table 20. Asia-Pacific TB Vaccines Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America TB Vaccines Sales by Type (2021-2026) & (W Units) Table 22. Latin America TB Vaccines Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa TB Vaccines Sales by Type (2021-2026) & (W Units) Table 24. Middle East and Africa TB Vaccines Sales by Type (2021-2026) & (US$ Million) Table 25. TB Vaccines Industry Trends Table 26. TB Vaccines Industry Drivers Table 27. TB Vaccines Industry Opportunities and Challenges Table 28. TB Vaccines Industry Restraints Table 29. Global TB Vaccines Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global TB Vaccines Revenue Market Share by Company (2021-2026) Table 31. Global TB Vaccines Sales by Company (2021-2026) & (W Units) Table 32. Global TB Vaccines Sales Share by Company (2021-2026) Table 33. Global TB Vaccines Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global TB Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global TB Vaccines Major Company Production Sites and Headquarters Table 36. Global TB Vaccines Company, Product Type & Application Table 37. Global TB Vaccines Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global TB Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global TB Vaccines Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global TB Vaccines Sales by Region (2021-2026) & (W Units) Table 42. Global TB Vaccines Sales Market Share in Volume by Region (2021-2026) Table 43. Global TB Vaccines Sales by Region (2021-2026) & (US$ Million) Table 44. Global TB Vaccines Sales Market Share in Value by Region (2021-2026) Table 45. Global TB Vaccines Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global TB Vaccines Sales by Region (2027-2032) & (W Units) Table 47. Global TB Vaccines Sales Market Share in Volume by Region (2027-2032) Table 48. Global TB Vaccines Sales by Region (2027-2032) & (US$ Million) Table 49. Global TB Vaccines Sales Market Share in Value by Region (2027-2032) Table 50. Global TB Vaccines Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global TB Vaccines Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global TB Vaccines Sales by Application (2021-2026) & (W Units) Table 53. Global TB Vaccines Sales Market Share in Volume by Application (2021-2026) Table 54. Global TB Vaccines Sales by Application (2021-2026) & (US$ Million) Table 55. Global TB Vaccines Sales Market Share in Value by Application (2021-2026) Table 56. Global TB Vaccines Price by Application (2021-2026) & (US$/Unit) Table 57. Global TB Vaccines Sales by Application (2027-2032) & (W Units) Table 58. Global TB Vaccines Sales Market Share in Volume by Application (2027-2032) Table 59. Global TB Vaccines Sales by Application (2027-2032) & (US$ Million) Table 60. Global TB Vaccines Sales Market Share in Value by Application (2027-2032) Table 61. Global TB Vaccines Price by Application (2027-2032) & (US$/Unit) Table 62. North America TB Vaccines Sales by Application (2021-2026) & (W Units) Table 63. North America TB Vaccines Sales by Application (2021-2026) & (US$ Million) Table 64. Europe TB Vaccines Sales by Application (2021-2026) & (W Units) Table 65. Europe TB Vaccines Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific TB Vaccines Sales by Application (2021-2026) & (W Units) Table 67. Asia-Pacific TB Vaccines Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America TB Vaccines Sales by Application (2021-2026) & (W Units) Table 69. Latin America TB Vaccines Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa TB Vaccines Sales by Application (2021-2026) & (W Units) Table 71. Middle East and Africa TB Vaccines Sales by Application (2021-2026) & (US$ Million) Table 72. China National Biotec Group Company Information Table 73. China National Biotec Group Business Overview Table 74. China National Biotec Group TB Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. China National Biotec Group TB Vaccines Product Portfolio Table 76. China National Biotec Group Recent Development Table 77. Sanofi Pasteur Company Information Table 78. Sanofi Pasteur Business Overview Table 79. Sanofi Pasteur TB Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Sanofi Pasteur TB Vaccines Product Portfolio Table 81. Sanofi Pasteur Recent Development Table 82. Merck & Co.,Inc Company Information Table 83. Merck & Co.,Inc Business Overview Table 84. Merck & Co.,Inc TB Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Merck & Co.,Inc TB Vaccines Product Portfolio Table 86. Merck & Co.,Inc Recent Development Table 87. Statens Serum Institut Company Information Table 88. Statens Serum Institut Business Overview Table 89. Statens Serum Institut TB Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Statens Serum Institut TB Vaccines Product Portfolio Table 91. Statens Serum Institut Recent Development Table 92. Serum Institute Company Information Table 93. Serum Institute Business Overview Table 94. Serum Institute TB Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Serum Institute TB Vaccines Product Portfolio Table 96. Serum Institute Recent Development Table 97. Japan BCG Laboratory Company Information Table 98. Japan BCG Laboratory Business Overview Table 99. Japan BCG Laboratory TB Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Japan BCG Laboratory TB Vaccines Product Portfolio Table 101. Japan BCG Laboratory Recent Development Table 102. InterVax Ltd Company Information Table 103. InterVax Ltd Business Overview Table 104. InterVax Ltd TB Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. InterVax Ltd TB Vaccines Product Portfolio Table 106. InterVax Ltd Recent Development Table 107. India Pvt. Ltd Company Information Table 108. India Pvt. Ltd Business Overview Table 109. India Pvt. Ltd TB Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. India Pvt. Ltd TB Vaccines Product Portfolio Table 111. India Pvt. Ltd Recent Development Table 112. GreenSignal Company Information Table 113. GreenSignal Business Overview Table 114. GreenSignal TB Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. GreenSignal TB Vaccines Product Portfolio Table 116. GreenSignal Recent Development Table 117. Bio Pharma Limited Company Information Table 118. Bio Pharma Limited Business Overview Table 119. Bio Pharma Limited TB Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Bio Pharma Limited TB Vaccines Product Portfolio Table 121. Bio Pharma Limited Recent Development Table 122. North America TB Vaccines Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 123. North America TB Vaccines Sales by Country (2021-2026) & (W Units) Table 124. North America TB Vaccines Sales Market Share by Country (2021-2026) Table 125. North America TB Vaccines Sales Forecast by Country (2027-2032) & (W Units) Table 126. North America TB Vaccines Sales Market Share Forecast by Country (2027-2032) Table 127. North America TB Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. North America TB Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 129. North America TB Vaccines Market Share by Country (2021-2026) Table 130. North America TB Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. North America TB Vaccines Market Share Forecast by Country (2027-2032) Table 132. Europe TB Vaccines Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 133. Europe TB Vaccines Sales by Country (2021-2026) & (W Units) Table 134. Europe TB Vaccines Sales Market Share by Country (2021-2026) Table 135. Europe TB Vaccines Sales Forecast by Country (2027-2032) & (W Units) Table 136. Europe TB Vaccines Sales Market Share Forecast by Country (2027-2032) Table 137. Europe TB Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Europe TB Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 139. Europe TB Vaccines Market Share by Country (2021-2026) Table 140. Europe TB Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Europe TB Vaccines Market Share Forecast by Country (2027-2032) Table 142. Asia-Pacific TB Vaccines Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 143. Asia-Pacific TB Vaccines Sales by Country (2021-2026) & (W Units) Table 144. Asia-Pacific TB Vaccines Sales Market Share by Country (2021-2026) Table 145. Asia-Pacific TB Vaccines Sales Forecast by Country (2027-2032) & (W Units) Table 146. Asia-Pacific TB Vaccines Sales Market Share Forecast by Country (2027-2032) Table 147. Asia-Pacific TB Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Asia-Pacific TB Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 149. Asia-Pacific TB Vaccines Market Share by Country (2021-2026) Table 150. Asia-Pacific TB Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Asia-Pacific TB Vaccines Market Share Forecast by Country (2027-2032) Table 152. Latin America TB Vaccines Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 153. Latin America TB Vaccines Sales by Country (2021-2026) & (W Units) Table 154. Latin America TB Vaccines Sales Market Share by Country (2021-2026) Table 155. Latin America TB Vaccines Sales Forecast by Country (2027-2032) & (W Units) Table 156. Latin America TB Vaccines Sales Market Share Forecast by Country (2027-2032) Table 157. Latin America TB Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Latin America TB Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 159. Latin America TB Vaccines Market Share by Country (2021-2026) Table 160. Latin America TB Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Latin America TB Vaccines Market Share Forecast by Country (2027-2032) Table 162. Middle East and Africa TB Vaccines Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 163. Middle East and Africa TB Vaccines Sales by Country (2021-2026) & (W Units) Table 164. Middle East and Africa TB Vaccines Sales Market Share by Country (2021-2026) Table 165. Middle East and Africa TB Vaccines Sales Forecast by Country (2027-2032) & (W Units) Table 166. Middle East and Africa TB Vaccines Sales Market Share Forecast by Country (2027-2032) Table 167. Middle East and Africa TB Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Middle East and Africa TB Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 169. Middle East and Africa TB Vaccines Market Share by Country (2021-2026) Table 170. Middle East and Africa TB Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Middle East and Africa TB Vaccines Market Share Forecast by Country (2027-2032) Table 172. Key Raw Materials Table 173. Raw Materials Key Suppliers Table 174. TB Vaccines Distributors List Table 175. TB Vaccines Customers List Table 176. Research Programs/Design for This Report Table 177. Authors List of This Report Table 178. Secondary Sources Table 179. Primary Sources List of Figures Figure 1. TB Vaccines Image Figure 2. Global TB Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global TB Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global TB Vaccines Sales (2021-2032) & (W Units) Figure 5. Immunotherapeutic Vaccines Image Figure 6. Global Immunotherapeutic Vaccines Sales YoY Growth (2021-2032) & (W Units) Figure 7. Booster Vaccines Image Figure 8. Global Booster Vaccines Sales YoY Growth (2021-2032) & (W Units) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 11. Global TB Vaccines Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global TB Vaccines Market Share by Type 2025 VS 2032 Figure 13. North America TB Vaccines Sales Market Share in Volume by Type in 2025 Figure 14. North America TB Vaccines Sales Market Share in Value by Type in 2025 Figure 15. Europe TB Vaccines Sales Market Share in Volume by Type in 2025 Figure 16. Europe TB Vaccines Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific TB Vaccines Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific TB Vaccines Sales Market Share in Value by Type in 2025 Figure 19. Latin America TB Vaccines Sales Market Share in Volume by Type in 2025 Figure 20. Latin America TB Vaccines Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa TB Vaccines Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa TB Vaccines Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 TB Vaccines Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Private Clinics Image Figure 26. Global Private Clinics Sales YoY Growth (2021-2032) & (W Units) Figure 27. Research Institutes Image Figure 28. Global Research Institutes Sales YoY Growth (2021-2032) & (W Units) Figure 29. Hospitals Image Figure 30. Global Hospitals Sales YoY Growth (2021-2032) & (W Units) Figure 31. Global TB Vaccines Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global TB Vaccines Market Share by Application 2025 VS 2032 Figure 33. North America TB Vaccines Sales Market Share in Volume by Application in 2025 Figure 34. North America TB Vaccines Sales Market Share in Value by Application in 2025 Figure 35. Europe TB Vaccines Sales Market Share in Volume by Application in 2025 Figure 36. Europe TB Vaccines Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific TB Vaccines Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific TB Vaccines Sales Market Share in Value by Application in 2025 Figure 39. Latin America TB Vaccines Sales Market Share in Volume by Application in 2025 Figure 40. Latin America TB Vaccines Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa TB Vaccines Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa TB Vaccines Sales Market Share in Value by Application in 2025 Figure 43. North America TB Vaccines Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 44. North America TB Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America TB Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America TB Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe TB Vaccines Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 48. Europe TB Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe TB Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe TB Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific TB Vaccines Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 52. Asia-Pacific TB Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific TB Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific TB Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America TB Vaccines Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 56. Latin America TB Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America TB Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America TB Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa TB Vaccines Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 60. Middle East and Africa TB Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa TB Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa TB Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. TB Vaccines Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. TB Vaccines Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Immunotherapeutic Vaccines
  • Booster Vaccines
  • Others
Applications
  • Private Clinics
  • Research Institutes
  • Hospitals
Companies covered
  • China National Biotec Group
  • Sanofi Pasteur
  • Merck & Co.,Inc
  • Statens Serum Institut
  • Serum Institute
  • Japan BCG Laboratory
  • InterVax Ltd
  • India Pvt. Ltd
  • GreenSignal
  • Bio Pharma Limited

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global TB Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global TB Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.3 TB Vaccines Market by Type
  6. 1.3.1 Immunotherapeutic Vaccines
  7. 1.3.2 Booster Vaccines
  8. 1.3.3 Others
  9. 1.4 Global TB Vaccines Market Size by Type
  10. 1.4.1 Global TB Vaccines Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global TB Vaccines Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global TB Vaccines Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America TB Vaccines Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe TB Vaccines Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific TB Vaccines Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America TB Vaccines Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa TB Vaccines Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 TB Vaccines Industry Trends
  2. 2.2 TB Vaccines Industry Drivers
  3. 2.3 TB Vaccines Industry Opportunities and Challenges
  4. 2.4 TB Vaccines Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by TB Vaccines Revenue (2021-2026)
  2. 3.2 Global Top Players by TB Vaccines Sales (2021-2026)
  3. 3.3 Global Top Players by TB Vaccines Price (2021-2026)
  4. 3.4 Global TB Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global TB Vaccines Major Company Production Sites & Headquarters
  6. 3.6 Global TB Vaccines Company, Product Type & Application
  7. 3.7 Global TB Vaccines Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global TB Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 TB Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 TB Vaccines Tier 1, Tier 2, and Tier 3
4 TB Vaccines Regional Status and Outlook
  1. 4.1 Global TB Vaccines Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global TB Vaccines Historic Market Size by Region
  3. 4.2.1 Global TB Vaccines Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global TB Vaccines Sales in Value by Region (2021-2026)
  5. 4.2.3 Global TB Vaccines Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global TB Vaccines Forecasted Market Size by Region
  7. 4.3.1 Global TB Vaccines Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global TB Vaccines Sales in Value by Region (2027-2032)
  9. 4.3.3 Global TB Vaccines Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 TB Vaccines by Application
  1. 5.1 TB Vaccines Market by Application
  2. 5.1.1 Private Clinics
  3. 5.1.2 Research Institutes
  4. 5.1.3 Hospitals
  5. 5.2 Global TB Vaccines Market Size by Application
  6. 5.2.1 Global TB Vaccines Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global TB Vaccines Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global TB Vaccines Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America TB Vaccines Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe TB Vaccines Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific TB Vaccines Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America TB Vaccines Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa TB Vaccines Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 China National Biotec Group
  2. 6.1.1 China National Biotec Group Company Information
  3. 6.1.2 China National Biotec Group Business Overview
  4. 6.1.3 China National Biotec Group TB Vaccines Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 China National Biotec Group TB Vaccines Product Portfolio
  6. 6.1.5 China National Biotec Group Recent Developments
  7. 6.2 Sanofi Pasteur
  8. 6.2.1 Sanofi Pasteur Company Information
  9. 6.2.2 Sanofi Pasteur Business Overview
  10. 6.2.3 Sanofi Pasteur TB Vaccines Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sanofi Pasteur TB Vaccines Product Portfolio
  12. 6.2.5 Sanofi Pasteur Recent Developments
  13. 6.3 Merck & Co.,Inc
  14. 6.3.1 Merck & Co.,Inc Company Information
  15. 6.3.2 Merck & Co.,Inc Business Overview
  16. 6.3.3 Merck & Co.,Inc TB Vaccines Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Merck & Co.,Inc TB Vaccines Product Portfolio
  18. 6.3.5 Merck & Co.,Inc Recent Developments
  19. 6.4 Statens Serum Institut
  20. 6.4.1 Statens Serum Institut Company Information
  21. 6.4.2 Statens Serum Institut Business Overview
  22. 6.4.3 Statens Serum Institut TB Vaccines Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Statens Serum Institut TB Vaccines Product Portfolio
  24. 6.4.5 Statens Serum Institut Recent Developments
  25. 6.5 Serum Institute
  26. 6.5.1 Serum Institute Company Information
  27. 6.5.2 Serum Institute Business Overview
  28. 6.5.3 Serum Institute TB Vaccines Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Serum Institute TB Vaccines Product Portfolio
  30. 6.5.5 Serum Institute Recent Developments
  31. 6.6 Japan BCG Laboratory
  32. 6.6.1 Japan BCG Laboratory Company Information
  33. 6.6.2 Japan BCG Laboratory Business Overview
  34. 6.6.3 Japan BCG Laboratory TB Vaccines Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Japan BCG Laboratory TB Vaccines Product Portfolio
  36. 6.6.5 Japan BCG Laboratory Recent Developments
  37. 6.7 InterVax Ltd
  38. 6.7.1 InterVax Ltd Company Information
  39. 6.7.2 InterVax Ltd Business Overview
  40. 6.7.3 InterVax Ltd TB Vaccines Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 InterVax Ltd TB Vaccines Product Portfolio
  42. 6.7.5 InterVax Ltd Recent Developments
  43. 6.8 India Pvt. Ltd
  44. 6.8.1 India Pvt. Ltd Company Information
  45. 6.8.2 India Pvt. Ltd Business Overview
  46. 6.8.3 India Pvt. Ltd TB Vaccines Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 India Pvt. Ltd TB Vaccines Product Portfolio
  48. 6.8.5 India Pvt. Ltd Recent Developments
  49. 6.9 GreenSignal
  50. 6.9.1 GreenSignal Company Information
  51. 6.9.2 GreenSignal Business Overview
  52. 6.9.3 GreenSignal TB Vaccines Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 GreenSignal TB Vaccines Product Portfolio
  54. 6.9.5 GreenSignal Recent Developments
  55. 6.10 Bio Pharma Limited
  56. 6.10.1 Bio Pharma Limited Company Information
  57. 6.10.2 Bio Pharma Limited Business Overview
  58. 6.10.3 Bio Pharma Limited TB Vaccines Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Bio Pharma Limited TB Vaccines Product Portfolio
  60. 6.10.5 Bio Pharma Limited Recent Developments
7 North America by Country
  1. 7.1 North America TB Vaccines Sales by Country
  2. 7.1.1 North America TB Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America TB Vaccines Sales by Country (2021-2026)
  4. 7.1.3 North America TB Vaccines Sales Forecast by Country (2027-2032)
  5. 7.2 North America TB Vaccines Market Size by Country
  6. 7.2.1 North America TB Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America TB Vaccines Market Size by Country (2021-2026)
  8. 7.2.3 North America TB Vaccines Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe TB Vaccines Sales by Country
  2. 8.1.1 Europe TB Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe TB Vaccines Sales by Country (2021-2026)
  4. 8.1.3 Europe TB Vaccines Sales Forecast by Country (2027-2032)
  5. 8.2 Europe TB Vaccines Market Size by Country
  6. 8.2.1 Europe TB Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe TB Vaccines Market Size by Country (2021-2026)
  8. 8.2.3 Europe TB Vaccines Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific TB Vaccines Sales by Country
  2. 9.1.1 Asia-Pacific TB Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific TB Vaccines Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific TB Vaccines Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific TB Vaccines Market Size by Country
  6. 9.2.1 Asia-Pacific TB Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific TB Vaccines Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific TB Vaccines Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America TB Vaccines Sales by Country
  2. 10.1.1 South America TB Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America TB Vaccines Sales by Country (2021-2026)
  4. 10.1.3 South America TB Vaccines Sales Forecast by Country (2027-2032)
  5. 10.2 South America TB Vaccines Market Size by Country
  6. 10.2.1 South America TB Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America TB Vaccines Market Size by Country (2021-2026)
  8. 10.2.3 South America TB Vaccines Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa TB Vaccines Sales by Country
  2. 11.1.1 Middle East and Africa TB Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa TB Vaccines Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa TB Vaccines Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa TB Vaccines Market Size by Country
  6. 11.2.1 Middle East and Africa TB Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa TB Vaccines Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa TB Vaccines Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 TB Vaccines Value Chain Analysis
  2. 12.1.1 TB Vaccines Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 TB Vaccines Production Mode & Process
  7. 12.2 TB Vaccines Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 TB Vaccines Distributors
  10. 12.2.3 TB Vaccines Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst